Page results
-
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
-
Our staff have rated UCLH as the top trust in London to work at, and the third best in the country, during what has been another incredibly challenging year.
-
UCLH has declared a climate and health emergency and has published an action plan to reach net zero carbon dioxide emissions.
-
North Mid, UCLH and Whittington Health are running a fun, uplifting, informative event for people with sickle cell on Saturday 25th June 2022.
-
Information about our UCLH Charity, charity funds and associated charities.
-
UCLH has recruited the first patient in Europe for an early phase trial of a potential new medicine for patients that have a specific sub-type of multiple myeloma (MM), a type of bone marrow cancer.
-
Having originally studied classics, and having first worked in publishing and in the British Library, I became a lawyer and spent ten years in commercial litigation practice in the City.
-
On Saturday 25 June 2022, UCLH partnered with North Middlesex University Hospital and Whittington Health to run a summer sickle cell event at Tottenham Hotspur Stadium for children and young people with sickle cell disorder.
-
UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.
-
Christmas is an exciting time even if it will be a bit different for us all this year. We might be spending more time inside, making us less active than usual for this time of year. However, it is still a good time to relax and enjoy some Christmas treats.
File results
-
FOI/2023/0808 - Full blood count tests for chemotherapy cancer treatment
-
FOI/2023/0806 - Patient Group Directions (PGDs)
-
FOI/2023/0800 - Bank staff hire time/ recruitment/ mandatory training
-
FOI/2023/0799 - Bronchiectasis pathway
-
FOI/2023/0794 - Pandas/ PANS/ immune mediated neuro behaviour conditions
-
FOI/2023/0792 - Bank and agency strategy for the ICB
-
FOI/2023/0788 - Networking/ WiFi/ telephony hardware/ unified communications refresh
-
FOI/2023/0787 - HIMSS INFRAM assessment/ digital strategy
-
FOI/2023/0751 - Patient numbers and drug spend for Waldenstrom's Macroglobulinaemia
-
FOI/2023/0753 - Drug-related admissions in A&E 2018-2023